- Home
- ONC vs ABEV Comparison
ONC vs ABEV Comparison
Compare ONC & ABEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONC | ABEV |
|---|---|---|
| Founded | 2010 | 1885 |
| Country | Switzerland | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8B | 33.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ONC | ABEV |
|---|---|---|
| Price | $322.79 | $2.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 5 |
| Target Price | ★ $369.50 | $2.53 |
| AVG Volume (30 Days) | 332.1K | ★ 32.3M |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 7.00% |
| EPS Growth | N/A | ★ 15.78 |
| EPS | ★ 0.58 | 0.19 |
| Revenue | $4,972,687,000.00 | ★ $16,975,691,794.00 |
| Revenue This Year | $36.37 | $3.57 |
| Revenue Next Year | $22.04 | $4.38 |
| P/E Ratio | $553.50 | ★ $12.85 |
| Revenue Growth | ★ 53.47 | 9.79 |
| 52 Week Low | $170.99 | $1.76 |
| 52 Week High | $385.22 | $2.64 |
Technical Indicators
Market Signals| Indicator | ONC | ABEV |
|---|---|---|
| Relative Strength Index (RSI) | 42.54 | 49.44 |
| Support Level | $325.00 | $2.48 |
| Resistance Level | $340.98 | $2.63 |
| Average True Range (ATR) | 13.32 | 0.06 |
| MACD | -3.46 | -0.01 |
| Stochastic Oscillator | 16.88 | 21.43 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
About ABEV Ambev S.A.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.